Rein Therapeutics, Inc. Fair Value Disclosure
The following tables present information about the Company’s assets that are measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values:
|
|
December 31, 2025 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
||||
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds |
|
$ |
3,130 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,130 |
|
Treasury bills |
|
|
4 |
|
|
|
— |
|
|
|
— |
|
|
|
4 |
|
|
|
$ |
3,134 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,134 |
|
|
|
December 31, 2024 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
||||
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds |
|
$ |
2,539 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,539 |
|
Treasury bills |
|
|
8,341 |
|
|
|
— |
|
|
|
— |
|
|
|
8,341 |
|
|
|
$ |
10,880 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,880 |
|
During the years ended December 31, 2025 and 2024, there were no transfers between levels.
Want the next Rein Therapeutics, Inc. fair value disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Rein Therapeutics, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 26, 2026 | Showing above |
| 2024 | Apr 7, 2025 | |
| 2023 | Apr 15, 2024 | |
| 2022 | Mar 20, 2023 | |
| 2021 | Mar 28, 2022 | |
| 2020 | Mar 24, 2021 | |
| 2019 | Mar 30, 2020 | |
| 2018 | Mar 29, 2019 | |
| 2017 | Apr 2, 2018 | |
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.